Background: GAAPs regulate intracellular Ca2+ fluxes, cell migration, and apoptosis.
Results: GAAP forms a cation-selective channel, and residues involved in its ion-conducting properties were identified.
Conclusion: Mutations within the pore demonstrate that GAAP effects on apoptosis and migration are separable.
Significance: Characterization of the pore region of GAAP provides insight into the mechanism of action of this novel and highly conserved ion channel.
Keywords: Electrophysiology, Ion Channel, Lipid Bilayer, Membrane Protein, Viral Protein
Abstract
Golgi anti-apoptotic proteins (GAAPs) are multitransmembrane proteins that are expressed in the Golgi apparatus and are able to homo-oligomerize. They are highly conserved throughout eukaryotes and are present in some prokaryotes and orthopoxviruses. Within eukaryotes, GAAPs regulate the Ca2+ content of intracellular stores, inhibit apoptosis, and promote cell adhesion and migration. Data presented here demonstrate that purified viral GAAPs (vGAAPs) and human Bax inhibitor 1 form ion channels and that vGAAP from camelpox virus is selective for cations. Mutagenesis of vGAAP, including some residues conserved in the recently solved structure of a related bacterial protein, BsYetJ, altered the conductance (E207Q and D219N) and ion selectivity (E207Q) of the channel. Mutation of residue Glu-207 or -178 reduced the effects of GAAP on cell migration and adhesion without affecting protection from apoptosis. In contrast, mutation of Asp-219 abrogated the anti-apoptotic activity of GAAP but not its effects on cell migration and adhesion. These results demonstrate that GAAPs are ion channels and define residues that contribute to the ion-conducting pore and affect apoptosis, cell adhesion, and migration independently.
Introduction
Golgi anti-apoptotic protein (GAAP),4 also known as TMBIM4 (transmembrane Bax (Bcl-2-associated X protein) inhibitor-1 motif-containing 4), is a highly conserved, hydrophobic protein present throughout eukaryotes. GAAPs from vertebrates, insects, and plants share a remarkable conservation of size, primary sequence, and hydrophobicity profile, suggesting highly conserved structures (1). Phylogenetic analyses suggest that GAAPs arose very early in eukaryotic evolution and that most members of the TMBIM family arose from a GAAP-like progenitor about 2,000 million years ago (2, 3). The human GAAP (hGAAP) was proposed to be an essential housekeeping protein based on microarray analysis (4), its ubiquitous expression in all human tissues tested, and its requirement for cell viability (1).
The GAAP gene, 6L, was discovered in camelpox virus (CMLV) and encodes a protein with 237 amino acid residues (5) that is also present in cowpox virus (CPXV) and in 3 of 16 strains of vaccinia virus (VACV). In these viruses, the protein is very highly conserved (>98% amino acid identity). Although not essential for the replication of VACV in cell culture, vGAAP affected the virulence of the virus in vivo, indicating an important function (1). vGAAP and hGAAP share 73% amino acid identity, the same length, and a conserved hydrophobicity profile (1). This high degree of conservation between a VACV protein and a human orthologue is unusual, because such sequence identities are commonly only about 20–30% (6–8). hGAAP and vGAAP are so similar that expression of vGAAP can prevent apoptosis following knockdown of endogenous hGAAP with siRNA (1). Both vGAAP and hGAAP localize predominantly to the Golgi apparatus (1). hGAAP, vGAAP, and human Bax inhibitor-1 (hBI-1), another widely expressed TMBIM protein, share similar functions and secondary structures. The three proteins inhibit apoptosis induced by a wide range of stimuli (1, 9), and all contain a conserved UPF0005 motif (2, 10), both characteristic features of the TMBIM family.
The mRNA for hGAAP is significantly up-regulated in some human malignant tissues compared with normal tissues (11, 12). The high expression of hGAAP mRNA in glioblastoma multiforme tumors is associated with poor outcomes (12). Dysregulation of hGAAP in non-small cell lung carcinoma samples led to hGAAP being proposed as a novel candidate prognostic marker for this disease in patients who have never smoked (11). Expression of BI-1 is also dysregulated in some human malignant tissues, such as breast and prostate cancers (13–16), and overexpression of BI-1 increases cancer progression and metastasis in mice (17, 18). The structural and functional relatedness of hGAAP and BI-1 led us to suggest that hGAAP, like BI-1 (19), may be important for cancer development and a target for new anti-cancer drugs.
Overexpression of hGAAP lowers the Ca2+ content of the endoplasmic reticulum (ER) and Golgi apparatus, whereas inhibiting expression of endogenous hGAAP has the opposite effects (20). hGAAP also regulates focal adhesion dynamics and cell adhesion and migration and promotes Ca2+ influx across the plasma membrane via store-operated Ca2+ entry (21). However, the molecular mechanisms by which hGAAP affects Ca2+ fluxes are not known.
hGAAP does not interact with the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) 2b that mediates Ca2+ uptake into the ER but was reported to interact with inositol 1,4,5-trisphosphate receptors (IP3Rs), through which it might affect Ca2+ homeostasis (20). Alternatively, GAAP may form an ion channel or exchanger directly. Overexpression of BI-1 reduces the Ca2+ content of intracellular stores (22) and mediates Ca2+/H+ fluxes when reconstituted into liposomes (22, 23). In addition, ionic currents have been recorded from the plasma membrane of cells overexpressing BI-1 (24).
Bioinformatic analyses of the membrane topology of hGAAP, vGAAP, and other TMBIM family members predicted that each protein has either six or seven transmembrane domains (TMDs) (25). However, topology maps of vGAAP, hGAAP, and hBI-1 deduced using antibody accessibility indicated that for all three proteins, the N and C termini were cytosolic, consistent with six TMDs linked by short interconnecting regions (25, 26). An epitope tag inserted within the hydrophilic region between the sixth and seventh hydrophobic regions was accessible to antibody, suggesting that the seventh hydrophobic region might form a re-entrant membrane loop near the charged C terminus (25). For all three proteins, pH affected their homo-oligomerization (22, 27).
While the present work was in progress, a high resolution structure of BsYetJ, a bacterial protein related to hBI-1 and hGAAP (18 and 21% amino acid identity, respectively), was published (28). This structure revealed seven TMDs, with TMD7 at the core of the structure. Increasing pH (from 6 to 8) caused a substantial lateral movement of TMD2, suggestive of channel gating (28). The first six of the seven α-helices in BsYetJ match their locations within the topological map of GAAPs (25, 28). However, the origin of the difference in the apparent organization of TMD7 between vGAAP, hGAAP, and BsYetJ is not clear. It is possible that attaching a hydrophilic tag, such as yellow fluorescent protein (YFP) or a hemagglutinin (HA) epitope, at the C terminus of GAAPs induced an aberrant topology, although GAAP tagged in this way retained its function as a regulator of apoptosis, adhesion, and migration (1, 21, 25). It is also possible that the crystallization conditions used for such a highly hydrophobic protein as BsYetJ might have altered its topology. Alternatively, there may be genuine differences in the membrane topologies of GAAPs/hBI-1 and the distantly related bacterial protein.
Here electrophysiological recordings from purified vGAAPs and hBI-1 reconstituted into lipid bilayers demonstrate that these proteins form ion channels and that vGAAP is selective for cations. Mutation of conserved residues toward the C terminus of vGAAP increased the single-channel conductance (E207Q or D219N) and changed the ion selectivity (E207Q). This suggests that these residues are located within the channel pore. Of these mutations, only E207Q reduced the effects of GAAP on cell migration and adhesion. Conversely, mutation of Asp-219, but not of Glu-207, abolished the anti-apoptotic effect of vGAAP. The ancient origins of GAAPs and their striking level of conservation suggest that these findings are likely to be relevant to other GAAPs and members of the TMBIM family.
EXPERIMENTAL PROCEDURES
Phylogenetic and Bioinformatics Analyses
Searches for GAAP orthologues or known ion channels with regions of sequence similarity to GAAP were carried out with BLASTP (29) using full-length or partial GAAP query sequences. Multiple amino acid sequence alignments were generated using ClustalW (30). For the generation of sequence conservation plots, ClustalW protein alignments were quantified using Scorecons (31) to generate a residue conservation score list. Hydrophobicity profiles were generated using the Kyte and Doolittle algorithm (32), and multiple profiles were overlapped using GraphPad Prism version 5.
The GenBankTM accession numbers for known and putative GAAP orthologues discussed in this paper are as follows: CMLV (AAG37461.1), VACV strain Evans (AAV98625), CPXV (ADZ30397.1), Homo sapiens (AAF14868), Canis lupus familiaris (XP_531662), Bos taurus (AAI51433), Rattus norvegicus (AAH60596), Gallus gallus (XP_001235093), Danio rerio (NP_998303), Trichoplax adhaerens (XP_002108506), Caenorhabditis elegans (NP_509543), Schizosaccharomyces pombe (NP_588431), Arabidopsis thaliana (NP_193209), Penicillium chrysogenum (XP_002568682.1), Campylobacter jejuni (WP_002862428.1), Helicobacter pylori (WP_001240234.1), Candidatus Chloracidobacterium thermophilum (ABV27378.1), Tuber melanosporum (XP_002836789), Cerapachys biroi (EZA59874), Tribolium castaneum (XP_969476), Genlisea aurea (EPS68151), Zea mays (EGU84019), and Saccharomyces cerevisiae (NP_014094). The accession numbers of other proteins used are as follows: H. sapiens TMBIM1/Recs1 (AAH26693), H. sapiens TMBIM2/FAIM2 (Q9BWQ8), H. sapiens TMBIM3/GRINA (NP_001009184), H. sapiens TMBIM5/Ghitm (Q9H3K2), H. sapiens TMBIM6/BI-1 (P55061), Bacillus subtilis YetJ (O31539), H. sapiens RyR1 (P21817), H. sapiens Cav2.1 (O00555), Streptomyces lividans KcsA (P0A334), Bacillus cereus NaK (2AHZ_A), and Mus musculus KCa1.1 (Q08460).
Cell Culture and Transfection
U2-OS and HEK 293T cells were grown in DMEM (Life Technologies) supplemented with 10% fetal bovine serum (FBS), 50 units/ml penicillin, 50 μg/ml streptomycin, and 2 mm l-glutamine. Plasmid transfections used FuGENE 6 (Roche Applied Science) according to the manufacturer's instructions.
Expression Plasmids and Stable Cell Lines
Full-length CMLV GAAP was amplified by PCR with a 3′ HA epitope incorporated within the reverse primer and cloned into vector pcDNA3.1+ (Invitrogen) using restriction sites BamHI/EcoRI. Single amino acid mutations G152A, E178Q, E207Q, and D219N were inserted into CMLV GAAP-HA using the QuikChange multiple-site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. PCR-based site-directed mutagenesis was performed using a forward primer containing each point mutation flanked with overhangs complementary to adjacent GAAP sequences. U2-OS cells were transfected with the empty pcDNA3.1+ vector or the vector encoding HA-tagged CMLV GAAP or its mutant forms. Transfected cells were selected for their resistance to 500 μg/ml neomycin (Invitrogen). The CMLV GAAP alleles were subcloned into a lentiviral bicistronic expression vector using restriction sites BamHI/EcoRI. HEK 293T cells were co-transfected with 0.5 μg of lentivirus packaging vector, 0.5 μg of vesicular stomatitis virus glycoprotein G-expressing vector, and 0.76 μg of lentiviral bicistronic vector coding for the gene of interest and GFP in the first and second cistron, respectively. After 72 h, virions produced in the supernatant were harvested, and cell debris was removed by centrifugation (300 × g for 5 min) and filtration (0.45-μm pore size filter). U2-OS cells at 50% confluence were infected with the lentivirus preparation, and GFP-expressing cells were sorted using a MoFloMLS high speed cell sorter (Beckman Coulter). The U2-OS cell line expressing FLAG-tagged Bcl-XL was a gift from Dr. D. L. Veyer (University of Cambridge).
Immunoblotting
Cells were lysed at 4 °C in CHAPS lysis buffer (50 mm Tris-HCl, pH 7.5, 100 mm NaCl, 2 mm EDTA, 1% (w/v) CHAPS (Sigma-Aldrich), and protease and phosphatase inhibitor mixtures (Roche Applied Science)). The lysates were cleared by centrifugation (15,000 × g for 15 min), resolved on a 12% SDS-polyacrylamide gel, and transferred onto a nitrocellulose membrane. The antibody dilutions used were rabbit anti-FLAG (1:1,000; Sigma, F7425), rabbit anti-HA (1:10,000; Sigma, H6908), mouse anti-tubulin (1:10,000; Millipore, 05-829), rabbit anti-YFP/GFP (1:25,000; Abcam, ab290), and anti-SERCA (1:1,000; Calbiochem, 564702). Purified proteins were resolved on Novex 12% Tris/glycine gels (Invitrogen) in the absence of reducing agent and stained with Imperial stain (Pierce) or Coomassie Blue (R-250).
Immunoprecipitation
COS-7 cells at 70–80% confluence were transfected using Lipofectamine 2000 with empty pCI vector, plasmids encoding full-length or truncated IP3R1 with an N-terminal YFP tag (33), or YFP/GFP-tagged controls that localize to different organelles: pEYFP-ER (ER-YFP) (lumen of the ER; Clontech), YFP-lamin B1 (LamB1) (nucleus; Clontech), pEGFP-tubulin (GFP-Tub) (microtubules; Clontech), and pEYFP-C1 (cytosolic YFP; Clontech). 24 h after transfection, cells were infected at an multiplicity of infection of 3 for 16 h with recombinant VACV strain Evans lacking vGAAP (v-ΔGAAP) or with a C-terminally HA-tagged vGAAP (vGAAP Rev-HA) (1). Cells were harvested and lysed in 1% CHAPS buffer (50 mm Tris-HCl, pH 7.5, 500 mm NaCl, 2 mm EDTA, 1% CHAPS (w/v), protease inhibitors, and phosphatase inhibitors). After centrifugation (15,000 × g, 15 min, 4 °C), the supernatant was retained, and the total protein content was determined by a Bradford assay (Bio-Rad). Some of the supernatant was kept for gel analysis. After a 2-h incubation with protein G-Sepharose beads (Roche Applied Science), anti-GFP/YFP (1:200; Abcam) was added to the cell lysates and incubated overnight with gentle rocking. Protein G-Sepharose beads (40 μl) were then added, incubated for 2 h, and then washed four times with 1% CHAPS buffer. The whole cell extracts and immunoprecipitated proteins were resolved by SDS-PAGE and immunoblotted with anti-YFP/GFP, anti-HA, or anti-SERCA antibodies.
Apoptosis Assays
U2-OS cells were seeded in 96-well dishes at 104 cells/well in DMEM supplemented with 10% FBS. After 48 h, cells were mock-treated or treated with staurosporine (STS) (0.5 μm, 6 h), doxorubicin (DOXO) (3 μm, 48 h), or cycloheximide (CHX) (20 μg/ml) and human tumor necrosis factor α (TNF-α) (10 ng/ml) for 16 h in DMEM with 2% FBS. Media used for mock treatments were supplemented with concentrations of the solvents used to dissolve drugs: DMSO for STS or DOXO and Milli-Q water for CHX and TNF-α. Caspase-3 and -7 activity was determined according to the manufacturer's instructions, using the Caspase-Glo 3/7 substrate (Promega). The resulting luminescence, which is proportional to caspase-3/7 activity, was measured using a luminometer (Omega).
Cell Spreading Assay
U2-OS cells were detached with trypsin treatment, rinsed twice in DMEM containing 1% FBS, and seeded onto coverslips coated with 10 μg/ml fibronectin (Invitrogen). After 30 min at 37 °C, cells were fixed with 4% paraformaldehyde in 250 mm HEPES, pH 7.4, for 20 min. Image acquisition was performed by confocal microscopy (LSM 510 META, Carl Zeiss) with a ×63, 1.4 numerical aperture oil immersion objective. Mean cell areas were determined using ImageJ (National Institutes of Health).
Random Cell Migration Assay
U2-OS cells were seeded at low density (30%) in DMEM containing 10% FBS on 10 μg/ml fibronectin-coated (Invitrogen) 12-well plates. Cells were allowed to adhere for 4 h at 37 °C. Image acquisition was performed within an environmental chamber at 37 °C at 5-min intervals for 8 h from six different fields in each well using a wide field microscope (LSM 5 PASCAL, Zeiss), a ×10 objective, and a camera (AxioCam HRm; Carl Zeiss). Migration tracks were generated using the ImageJ Manual Tracking plugin, and tracks were analyzed using a Mathematica 7 notebook written in-house (provided by G. Dunn, King's College London) to calculate migration rates.
Expression and Purification of Proteins
GAAPs and hBI-1 were expressed in S. cerevisiae strain FGY217 (34). The engineered proteins had a cleavable C-terminal GFP-His8 tag and were expressed from the p424GAL1-TEVp-GFP-His8 vector under control of the galactose promoter (35). The proteins were purified and analyzed according to a protocol developed for other transmembrane proteins (36) in 150 mm NaCl, 20 mm Tris-base, 5% glycerol, and 0.06% lauryldimethylamine N-oxide, pH 7.5. The GFP-His8 tag was cleaved by adding His8-tagged tobacco etch virus protease to the purified GFP-His8-tagged protein at a molar ratio of 1:1 and digested overnight at 4 °C. Cleaved GFP-His8 and the His-tagged protease were removed using a HisTrap nickel column (GE Healthcare), and the untagged target proteins were harvested from the flow-through. The purified proteins were concentrated using an Amicon Ultra centrifugal filter with a molecular mass cut-off of 30 kDa (Millipore) and analyzed on a Superdex 200 size exclusion chromatography (SEC) column (GE Healthcare). Fractions corresponding to the purified target protein were collected and concentrated to 1.5–2 mg/ml. Purified adenosine A2A receptors (A2ARs) were provided by Dr. S. Singh (37).
Reconstitution of Proteins into Giant Unilamellar Vesicles (GUVs)
GUVs were produced by electroformation from a mixture of 1:10 cholesterol (Sigma) to 1,2-diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) dissolved in chloroform (Carl Roth). The lipid mixture (20 μl) was spread on the conductive side of an indium tin oxide-coated slide and allowed to dry for 10 min. The dried lipid film was covered with 1 m sorbitol (250 μl) enclosed within a greased O-ring and overlaid with a second indium tin oxide-coated slide with its conductive side facing the lipids. The assembly was then connected to a Vesicle Prep Pro (Nanion Technologies, Munich, Germany). The electric field parameters used for electroformation of GUVs were as follows: 5 Hz, 3 V, for 128 min at 20 °C. GUVs were then resuspended from the slide within the 1 m sorbitol overlay, collected, and stored at 4 °C for 3–4 days. Proteins were incorporated into GUVs by mixing purified protein (10 μl) with the GUV preparation (90 μl) (0.2 mg/ml final protein concentration). Bio-Beads SM-2 absorbents (152-8920, Bio-Rad) washed previously in methanol (3 × 10 min), ethanol (3 × 10 min), and Milli-Q water (6 × 5 min) were added (40 mg/ml, 15 min) and then removed three times during the reconstitution procedure (45 min total incubation) to remove excess detergent micelles. Protein-containing GUVs were stored at 4 °C and used within a few h for bilayer recordings.
Electrophysiological Recording
Single-channel recordings were performed with a Port-a-Patch system (Nanion Technologies) (38, 39) using NPC-1 borosilicate glass chips (5–10 megaohm resistance). Patch medium (5 μl) (140 mm KCl, 200 nm free Ca2+ (220 μm CaCl2 buffered with 0.5 mm BAPTA-Na4) and 10 mm HEPES-free acid, adjusted to pH 7 with KOH) was added to the cis side of the chip. Planar lipid bilayers were formed across the micrometer-sized aperture of the chip by suction after the addition of GUVs in 1 m sorbitol (5 μl) to the cis side (see Fig. 2C). The resistances were 1–10 gigaohms after formation of bilayers. Protein-reconstituted GUVs (5 μl) (in 15 mm NaCl, 2 mm Tris-base, 0.5% glycerol, 0.006% lauryldimethylamine N-oxide, and 0.9 m sorbitol, pH 7.25) were then added to allow incorporation of the purified protein into the bilayer. The final composition of the medium in the trans chamber (5 μl) was 140 mm KCl, 200 nm free Ca2+ (220 μm CaCl2 buffered with 0.5 mm BAPTA-Na4), 10 mm HEPES-free acid, adjusted to pH 7 with KOH. In the cis chamber (15 μl, ground), the final composition of the medium was 46.7 mm KCl, 200 nm free Ca2+ (73 μm CaCl2 buffered with 0.17 mm BAPTA-Na4), 5 mm NaCl, 3.33 mm HEPES-free acid, 0.67 m sorbitol, 0.67 mm Tris-base, pH 7 (see Fig. 2C). Recordings were acquired with PatchMaster software (Nanion Technologies) in the “on cell” mode, using an EPC 10 patch clamp amplifier (HEKA). Voltages are expressed as the potential on the cis side relative to the trans side. Single-channel currents are shown such that downward deflections (negative currents in the current-voltage curves) represent positive ions flowing from the trans to the cis side of the bilayer. For continuous current recordings, holding potentials were applied for 1-min intervals in increments of 20 mV or until bursts of spontaneous channel activity appeared. Voltage ramp recordings used a 1-s voltage ramp from −150 to +150 mV. Data were filtered at 2.9 kHz (Bessel filter, HEKA amplifier), digitized at 50 kHz, and exported to Clampfit (Molecular Devices) via MatLab (MathWorks). Recordings were analyzed using PatchMaster and Clampfit software. Gaussian curves were fitted to current amplitude histograms, and channel conductances and equilibrium potentials were calculated from linear regressions of the current-voltage relationships.
Homology Modeling
The modeling program I-TASSER (40–42) was used to create homology models of CMLV GAAP. The sequence of CMLV GAAP (GenBankTM protein accession number AAG37461.1) was used in structure-based sequence alignments to search for likely structures within the Protein Data Bank. These searches determined that the use of BsYetJ structures as templates gave the best models. The crystal structures of BsYetJ in the closed (Protein Data Bank entry 4PGR) and open (Protein Data Bank entry 4PGS) states were used as templates for the models shown. These models achieved confidence scores (C-scores) of −0.2 and −0.07, respectively, that are indicative of correct models, which usually have thresholds of >−1.5 (41).
RESULTS
vGAAPs and hBI-1 Are Ion Channels
To address the possibility that vGAAP may affect Ca2+ homeostasis via an interaction with IP3Rs, co-immunoprecipitation analyses were used to test whether the reported interaction of hGAAP with IP3Rs also occurs with vGAAP in the context of viral infection and to map the domains of IP3Rs involved in the interaction. YFP-tagged type-I IP3R (IP3R1) and a series of YFP-tagged truncation mutants of IP3R1 (33) were expressed in COS-7 cells, followed by infection with either v-ΔGAAP or revertant vGAAP-HA VACV (1) (Fig. 1). YFP- or GFP-tagged proteins that localize to different cellular organelles were included as negative controls. Full-length YFP-IP3R1 and fragments containing pairs of its six TMDs all immunoprecipitated vGAAP-HA (Fig. 1C), suggesting that these interactions are nonspecific, perhaps due to the hydrophobic nature of these proteins. The inability to detect regions within IP3R1 that interacted specifically with vGAAP led us to explore the potential for GAAPs to form ion channels directly.
To test whether GAAPs and hBI-1 form ion channels, vGAAPs were purified before electrophysiological analysis in artificial lipid bilayers. vGAAPs from CMLV and the Evans strain of VACV, rather than hGAAP, were chosen for analysis because they were more stable after expression in S. cerevisiae. After purification of the proteins expressed in S. cerevisiae, SEC (Fig. 2A) and non-reducing SDS-PAGE (Fig. 2B) revealed the expected presence of three or more oligomeric states of the vGAAPs and hBI-1 (22, 27). The SEC profiles indicated differences in the oligomeric composition of the purified proteins with the smallest (monomers) eluting last (Fig. 2A). Calculations of the areas under the curves indicated that CMLV GAAP and VACV GAAP favored oligomeric states (∼87 and ∼64% of total protein, respectively), whereas the monomer was dominant for hBI-1 (∼57% of total protein; Fig. 2A). Previous work showed that monomeric vGAAP was anti-apoptotic and reduced the Ca2+ content of intracellular stores (27). The functional properties of oligomeric vGAAP are unknown. To optimize opportunities for detecting channel activity, the purified proteins were used for functional reconstitution without separating the monomeric and oligomeric states (Fig. 2A, bracket).
The experimental conditions used for channel recordings are shown in Fig. 2C. Incorporation of purified proteins into GUVs and then into artificial planar bilayers (Fig. 2C) gave rise to spontaneous openings of single channels for both vGAAPs and hBI-1 (Fig. 2D). These conductances were not observed in untreated lipid bilayers after the addition of GUVs reconstituted in the absence of protein or after the addition of GUVs reconstituted with purified A2AR (37), which had been purified from yeast using methods similar to those used to purify vGAAPs and hBI-1 (Fig. 2D). These results provide the first direct evidence that vGAAPs form ion channels and that this function is conserved in another member of the TMBIM family, hBI-1.
Comparison of the Sequences of GAAPs with Ion Channels Identifies Putative Pore-lining Residues
To identify conserved residues within GAAPs that might contribute to formation of an ion channel, we searched for orthologues of GAAP encoded by the genomes of distantly related organisms. BLASTP searches using the sequences of hGAAP and VACV GAAP identified proteins throughout eukaryotes and in CPXV, fungi, and bacteria that share unusually high sequence identity and conserved length for proteins from such distantly related organisms (Table 1). These proteins also have strikingly similar hydrophobicity profiles to vGAAPs (Fig. 3), suggesting that they may be homologues of GAAP. An amino acid conservation plot confirmed the remarkable level of overall conservation within these proteins (Fig. 4A). The most conserved residues (red in Fig. 4A) are within TMD6 and the seventh hydrophobic region. Within the structure of BsYetJ, the seventh hydrophobic region forms a central helix (TMD7) that may line the pore (28), but we have proposed that this hydrophobic region forms a re-entrant loop in vGAAP (25). The subunits of many voltage-gated cation channels also contain 6–7 TMDs and a pore loop near the C terminus (43–45). These observations suggested that residues within the three C-terminal hydrophobic regions of GAAP were likely to contribute to the pore.
TABLE 1.
Known/putative GAAP orthologues | aa identity | aa | Accession no. | Available description |
---|---|---|---|---|
% | ||||
VACV Evans | 237 | AAV98625 | Golgi anti-apoptotic protein, BAX inhibitor (BI)-1/YccA-like protein family | |
CPXV | 97.5 | 236 | ADZ30397.1 | NMDA receptor-like protein |
CMLV | 95.4 | 237 | AAG37461 | 6L, GAAP |
H. sapiens | 75 | 238 | AAF14868 | S1R protein, z-protein, GAAP |
P. chrysogenum | 34.4 | 273 | XP_002568682.1 | Hypothetical protein GAAP-like |
C. chloracidobacterium | 30.5 | 239 | ABV27378.1 | Transmembrane BAX inhibitor-1 motif-containing 4 |
C. jejuni | 27.7 | 231 | WP_002862428.1 | Unknown membrane protein |
H. pylori | 24.8 | 230 | WP_001240234.1 | Membrane protein |
To identify residues or motifs within GAAP that might be involved in ion selectivity, conductance, or gating, BLASTP searches and sequence alignments with other ion channels were performed using full-length GAAP or individual TMDs. Glycine residues within the pores and selectivity filters of many cation channels facilitate gating (46), whereas both glycine (47, 48) and acidic residues (49, 50) contribute to conduction of ions. A G152AG154 motif in TMD5 of CMLV GAAP is absolutely conserved among eukaryotic GAAPs (Fig. 4D), among members of the TMBIM family (Fig. 4F), and in distantly related putative orthologues of GAAP in bacteria (Fig. 4E). In coarse sequence alignments, this motif aligned with residues near the selectivity filters of other cation channels (Fig. 4B). Likewise, the locations of conserved acidic residues in CMLV GAAP (Glu-178, Glu-207, and Asp-219) roughly aligned with similarly located acidic residues that are known to contribute to ion conduction in other channels (Fig. 4B) (49, 50). The conservation of SPE207E and D219IIN motifs is particularly striking (Fig. 4, D–F), appearing in all distantly related proteins in fungi and bacteria (Fig. 4E). Four of six TMBIM family members contain Glu-207, whereas all members contain Asp-219 (Fig. 4F). Both of these residues are also conserved in BsYetJ (Fig. 4C). The residue in BsYetJ (Asp-195) that aligns with Asp-219 of CMLV GAAP is part of a diaspartyl pH sensor that is proposed to keep the channel closed by preventing the movement of TMD2 that is required for channel opening (28). In hBI-1, the equivalent acidic residue (Asp-213) (Fig. 4F) is important for the loss of Ca2+ from the ER that is evoked by hBI-1 (26).
These analyses suggest that residues Gly-152, Glu-178, Glu-207, and Asp-219 within CMLV GAAP are strong candidates for residues expected to affect its behavior as an ion channel. Therefore, these residues were selected for mutagenesis.
Mutation of vGAAP Affects Single-channel Properties
To test the effects of the selected point mutations on the electrophysiological properties of GAAP, wild type (WT) CMLV GAAP and the putative pore mutants E207Q and D219N were expressed and purified from yeast. The G152A mutant could not be tested by this method because the protein was unstable after cleavage of the GFP-His8 tag used in the purification process. Analysis of the purified mutant proteins by SEC and non-reducing SDS-PAGE confirmed the expected presence of multiple oligomeric states (Fig. 5, A and B). The relative abundance of the monomer and oligomers differed between the mutants; for WT and E207Q, most protein was oligomeric (∼84 and ∼89%, respectively), whereas for D219N, only ∼66% of the protein formed oligomers (Fig. 5A). All of the monomeric and oligomeric states were pooled (Fig. 5A, bracket) before concentrating the proteins for electrophysiological analyses.
After reconstitution of purified protein into planar lipid bilayers, both the E207Q and D219N mutants of vGAAP generated spontaneous single-channel currents (Fig. 5, C and D). Relative to WT vGAAP, both mutations increased the amplitude of the single-channel currents recorded at a fixed voltage (Fig. 6, A and B). Current-voltage (i-V) relationships measured from stepwise changes in voltage (Fig. 6C) or from voltage ramps (Fig. 6, E and F) provided consistent results (Fig. 6, G and H); both mutants caused an increase in the conductance of the single channels (150 ± 13 picosiemens for E207Q, 79 ± 3 picosiemens for D219N, and 29 ± 3 picosiemens for WT vGAAP) (Fig. 6G). Under the ionic conditions used (see “Experimental Procedures”), the reversal potential (Vrev) of the single-channel activity produced by WT vGAAP (8 ± 4 mV) (Fig. 6H) is consistent with it forming a cation-selective channel. The reversal potential was similar for the D219N mutant (8 ± 4 mV), but it shifted to 36 ± 5 mV for the E207Q mutant (Fig. 6H), suggesting an effect of this mutation on ion selectivity. The open probability (Po) of the E207Q mutant was also altered compared with WT and D219N vGAAPs (Fig. 6D). The effects of mutations in vGAAP on single-channel properties establish unequivocally that the observed ion channel activity is attributable to the GAAP protein and not to unknown contaminants. These results demonstrate that mutations of Glu-207 and Asp-219 within vGAAP affect ion selectivity and/or single-channel conductance and suggest that these residues are located within the pore region.
Residue Asp-219 of CMLV GAAP Is Required for Protection from Apoptosis
To test the ability of CMLV GAAP and its mutants to inhibit apoptosis, U2-OS polyclonal cell lines were generated using a lentivirus system to deliver a bicistronic vector encoding GFP and CMLV GAAP or its mutants. Lentiviruses encoding GFP alone or in combination with Bcl-XL, a potent broad range inhibitor of apoptosis, were included as controls. GFP-expressing cells were selected by fluorescence-activated cell sorting, resulting in almost 100% of the population expressing the gene of interest (Fig. 7A). Immunoblotting of cell lysates showed similar levels of expression of WT and mutant CMLV GAAPs (Fig. 7B). In addition, the subcellular locations of mutant and WT CMLV GAAPs appeared similar and were consistent with staining patterns of hGAAP and VACV GAAP described previously (1, 25), although E207Q was also visible in the perinuclear region of some cells (Fig. 7A).
To assess the ability of CMLV GAAP mutants to inhibit apoptosis, the activities of caspase-3 and caspase-7 were measured after treatment with STS or DOXO to stimulate the intrinsic pathway of apoptosis or with CHX and TNF-α to stimulate the extrinsic pathway. As expected, Bcl-XL and, to a lesser extent, WT CMLV GAAP reduced apoptosis induced by CHX and TNF-α (Fig. 7C). Only one of the four mutants of CMLV GAAP (D219N) impaired the ability of GAAP to confer resistance to apoptosis induced by CHX and TNF-α (Fig. 7C). The same results were obtained when STS or DOXO was used to trigger apoptosis; only the D219N mutant failed to provide protection (Fig. 7, D and E, respectively). These results demonstrate that residue Asp-219 of CMLV GAAP is essential for inhibition of apoptosis induced through intrinsic and extrinsic pathways, whereas residues Glu-178, Glu-207, and Gly-152 are not.
Residues Glu-178 and Glu-207, but not Asp-219, of CMLV GAAP Are Important for Cell Spreading and Migration
To test the effects of point mutations in CMLV GAAP on cell adhesion and migration, neomycin-selected polyclonal U2-OS cell lines were generated that overexpressed WT or mutant CMLV GAAP with a C-terminal HA tag (Fig. 8B). The speed of random cell migration was assessed, and the areas of cell spreading after seeding were used to measure adhesion and spreading efficiency. Mutation of CMLV GAAPs did not affect their localization at the Golgi apparatus, as shown by co-localization of GAAP with the Golgi marker, GM130 (Fig. 8A), although, as seen with the lentivirally transduced cells (Fig. 8A), CMLV GAAP E207Q was also visible in the perinuclear region of some cells (Fig. 8A).
Cells expressing the empty vector (neo), WT CMLV GAAP, or the mutants E178Q, E207Q, and D219N were seeded onto fibronectin-coated dishes to monitor the migration of individual U2-OS cells. As reported previously for hGAAP (21), cells expressing WT CMLV GAAP migrated faster than neo and parental U2-OS control cells (Fig. 8, C and D) and also showed enhanced cell spreading (Fig. 8E). This demonstrates that increased cell adhesion and migration are features of hGAAP that are conserved in CMLV GAAP. The mutations E178Q and E207Q each abolished the effects of GAAP on cell spreading (Fig. 8E) and abolished (E178Q) or substantially attenuated (E207Q) the effects of GAAP on migration speed (Fig. 8D). In contrast, GAAP with the D219N mutation had effects similar to those of WT CMLV GAAP on both migration speed and cell spreading (Fig. 8, C–E). These results demonstrate that mutations in the putative pore region of CMLV GAAP have different effects; they can affect the anti-apoptotic activity of GAAP (D219N) or its ability to promote cell spreading and migration (E178Q and E207Q).
Structural Models of GAAP Define a Putative Pore
Using the crystal structures of BsYetJ in putative closed and open states (28) as templates, we constructed homology models of CMLV GAAP in the closed (Fig. 9, left column) and open states (Fig. 9, middle column). In the models, Glu-207 and Asp-219 are located at the cytosolic end of TMD7 and near the center of TMD7, respectively (Fig. 9, A and B). In the closed state model of CMLV GAAP, Asp-196 and Asp-219 are located close to each other within the putative pore and interact with Arg-90 in TMD2 (Fig. 9, A and B, left and right columns). This is similar to interactions within the putative closed state structure of BsYetJ (28), where two aspartates in the pore (Asp-171 and Asp-195 of BsYetJ, which align with Asp-196 and Asp-219 of CMLV GAAP, respectively) form salt bridges with each other, and one of these (Asp-171) forms salt bridges with a basic residue in TMD2 (Arg-60 of BsYetJ, which aligns with Arg-90 of CMLV GAAP). In BsYetJ, these interactions stabilize the closed state (28). Protonation of the aspartates (Asp-171 and Asp-195 in BsYetJ) disrupts these interactions, leading to displacement of TMD2 and opening of the channel (28). In the open state model of CMLV GAAP, Asp-196 and Asp-219 are located further from each other and from Arg-90, relative to their locations in the closed state (Fig. 9, A and B, middle column). This is consistent with a disruption of the interactions between these residues during opening of the CMLV GAAP channel. It is perhaps surprising that the mutation D219N failed to increase the Po of CMLV GAAP channels (Fig. 6D). The mechanisms underlying this effect are unclear. One possibility is that the predicted interactions involving Asp-196, Asp-219, and Arg-90 are already disrupted in WT CMLV GAAP under the experimental conditions used and that additional gating mechanisms exist. Surface models of CMLV GAAP show a predicted continuous pore that traverses the membrane in the open state but not the closed state (Fig. 9C). The locations of Glu-207 and Asp-219 at the cytosolic mouth and in the membrane-spanning region of the pore, respectively (Fig. 9, A and B), show that the acidic side chains of these residues are well placed to affect the passage of cations through the pore. This provides a possible mechanism for the effects of the neutralizing mutations E207Q and D219N on the conductance of single channels.
DISCUSSION
hGAAP regulates apoptosis, cell adhesion, and Ca2+ fluxes, and charged residues near the C terminus of hGAAP have been shown to be important for these effects (1, 20, 21). However, the mechanisms by which GAAP exerts these effects are unresolved. How the related TMBIM protein, hBI-1, exerts its effects on ER Ca2+ content and apoptosis is contentious, because BI-1 has been proposed to function as a Ca2+/H+ antiporter (22, 23) or a Ca2+ leak channel (26) or to increase the activity of IP3Rs (51, 52). The structure of BsYetJ, a related bacterial protein that shares about 20% amino acid identity with hBI-1 and hGAAP, has been interpreted by speculating that it forms a H+-regulated Ca2+ channel with a structure unlike that of any known ion channel (28). However, it remains to be confirmed whether BsYetJ forms an ion channel or exchanger (52).
Data presented here demonstrate that hGAAP, vGAAP, and hBI-1 are ion channels and that vGAAP is selective for cations. The spontaneous opening of these channels is consistent with suggestions that the loss of Ca2+ from intracellular stores after expression of hGAAP or hBI-1 is due to the activity of a passive leak channel (20, 22). Mutational analyses of amino acids that are conserved within GAAPs and orthologues from eukaryotes and prokaryotes identified residues that affect ion conductance and/or selectivity. Mutation of residues Asp-219 and Glu-207 in CMLV GAAP increased single-channel conductance, whereas E207Q also affected the ionic selectivity. Consistent with our results, mutation of a residue in hBI-1 that is equivalent to Asp-219 (Asp-213 in hBI-1) attenuated the ability of BI-1 to reduce the Ca2+ content of the ER (26). The importance of residues Glu-207 and Asp-219 for the function of the pore of GAAP channels, the conservation of these residues among distantly related proteins, and topological data indicating the likely positions of these residues in GAAPs and hBI-1 (25, 28) suggest that the seventh hydrophobic region of GAAP probably lines the pore of the channel (Fig. 9).
The structures of BsYetJ in the pH-regulated open and closed conformations were monomeric (28). A vGAAP mutant that can only form monomers retained its ability to inhibit apoptosis and reduce the Ca2+ content of intracellular stores (27). This is consistent with vGAAPs also functioning as monomers, although there is no direct evidence that monomeric GAAP forms a functional channel. Most ion channels are oligomers (50, 53), so the structure of BsYetJ and the activity of monomeric GAAPs is unusual. Nonetheless, both GAAPs and hBI-1 can oligomerize, and this is influenced by pH (22, 27), but the contribution of this oligomerization to ion channel function is unknown. Despite having a topology that is broadly reminiscent of the α-subunits of other ion channels (43, 44), GAAPs lack obvious signature motifs related to selectivity or conductance in other channels (44). This suggests that GAAPs may form channels with novel structures. The large size and 6–7 TMDs of GAAPs from orthopoxviruses make them unique among viral ion channels, and to our knowledge this study constitutes the first report of an ion channel encoded by poxviruses. Viroporins such as M2 channel from influenza virus and the p7 channel from hepatitis C virus are considered to be minimalistic versions of eukaryotic ion channels and typically have only 50–120 residues and no more than 1–3 TMDs (54–60). The lack of structural similarities between BsYetJ and known channels also supports the notion that GAAP channels have a unique mechanism of action (28).
GAAPs and hBI-1 inhibit apoptosis, increase cell spreading and migration speed, and reduce the Ca2+ content of intracellular stores. These properties are shared with CMLV GAAP. Whether these effects are independent or the result of a common core function of these proteins has been unclear. Our analyses of mutated residues within the putative pore of vGAAP demonstrate that the effects of GAAP on these activities are separable. Residues Glu-178 and Glu-207 are important for the vGAAP-mediated increase in cell migration and spreading, but not for protection from apoptosis. In contrast, residue Asp-219 is essential for the protective effects of vGAAP against apoptosis but not for enhanced adhesion and migration. Hence, two important biological effects of vGAAP, apoptosis and migration, are differentially susceptible to mutation of two pore-associated residues, Glu-207 and Asp-219. These mutants provide the first tools to study these complex functions in isolation (Table 2 and Fig. 9D).
TABLE 2.
The localization and characterization of the pore region of GAAP channels described by this study provides insight into their mechanism of action and highlights potential regions that could be targeted by new therapeutics for cancer. Given the ancient origins of GAAP and the remarkable level of topological and amino acid sequence conservation within the TMBIM family, these findings are probably also relevant to other members of the TMBIM family.
Acknowledgments
We thank Dr. D. L. Veyer (University of Cambridge) for providing the U2-OS lentivirus cell line overexpressing Bcl-XL, Dr. H. Laman (University of Cambridge) for providing the bicistronic lentiviral expression vector, Dr. O. Fedorenko (University of Cambridge) for help with analyses of single-channel recordings, N. Miller for assistance with cell sorting, Dr. S. Singh for providing purified A2AR, and Dr. M. Kreir (Nanion Technologies) for technical advice on the Port-a-Patch.
This work was supported by the United Kingdom Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the Wellcome Trust.
- GAAP
- Golgi anti-apoptotic protein
- hGAAP and vGAAP
- human and viral GAAP, respectively
- A2AR
- adenosine A2A receptor
- BI-1
- Bax inhibitor-1
- hBI-1
- human BI-1
- CHX
- cycloheximide
- CMLV
- camelpox virus
- CPXV
- cowpox virus
- DOXO
- doxorubicin
- ER
- endoplasmic reticulum
- GUV
- giant unilamellar vesicle
- IP3R
- inositol 1,4,5-trisphosphate receptor
- SEC
- size exclusion chromatography
- SERCA
- sarco/endoplasmic reticulum Ca2+-ATPase
- STS
- staurosporine
- TMBIM
- transmembrane BI-1-motif-containing
- TMD
- transmembrane domain
- VACV
- vaccinia virus.
REFERENCES
- 1. Gubser C., Bergamaschi D., Hollinshead M., Lu X., van Kuppeveld F. J., Smith G. L. (2007) A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog. 3, e17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Hu L., Smith T. F., Goldberger G. (2009) LFG: a candidate apoptosis regulatory gene family. Apoptosis 14, 1255–1265 [DOI] [PubMed] [Google Scholar]
- 3. Mariotti M., Smith T. F., Sudmant P. H., Goldberger G. (2014) Pseudogenization of testis-specific Lfg5 predates human/Neanderthal divergence. J. Hum. Genet. 59, 288–291 [DOI] [PubMed] [Google Scholar]
- 4. Lee S., Jo M., Lee J., Koh S. S., Kim S. (2007) Identification of novel universal housekeeping genes by statistical analysis of microarray data. J. Biochem. Mol. Biol. 40, 226–231 [DOI] [PubMed] [Google Scholar]
- 5. Gubser C., Smith G. L. (2002) The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J. Gen. Virol. 83, 855–872 [DOI] [PubMed] [Google Scholar]
- 6. Smith G. L., Chan Y. S. (1991) Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 72, 511–518 [DOI] [PubMed] [Google Scholar]
- 7. Alcamí A., Smith G. L. (1995) Vaccinia, cowpox, and camelpox viruses encode soluble γ interferon receptors with novel broad species specificity. J. Virol. 69, 4633–4639 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Moore J. B., Smith G. L. (1992) Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J. 11, 1973–1980 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Xu Q., Reed J. C. (1998) Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1, 337–346 [DOI] [PubMed] [Google Scholar]
- 10. Reimers K., Choi C. Y., Bucan V., Vogt P. M. (2008) The Bax inhibitor-1 (BI-1) family in apoptosis and tumorigenesis. Curr. Mol. Med. 8, 148–156 [DOI] [PubMed] [Google Scholar]
- 11. Wu X., Wang L., Ye Y., Aakre J. A., Pu X., Chang G. C., Yang P. C., Roth J. A., Marks R. S., Lippman S. M., Chang J. Y., Lu C., Deschamps C., Su W. C., Wang W. C., Huang M. S., Chang D. W., Li Y., Pankratz V. S., Minna J. D., Hong W. K., Hildebrandt M. A., Hsiung C. A., Yang P. (2013) Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 73, 4028–4038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Chen Q. R., Hu Y., Yan C., Buetow K., Meerzaman D. (2014) Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival. PLoS One 9, e105393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. del Carmen Garcia Molina Wolgien M., da Silva I. D., Villanova F. E., Yumi Otsuka A., Borra R. C., Lima Reis L. F., Carvalho A. F., Baracat E. C., Gebrim L. H. (2005) Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment. Eur. J. Gynaecol. Oncol. 26, 501–504 [PubMed] [Google Scholar]
- 14. Grzmil M., Kaulfuss S., Thelen P., Hemmerlein B., Schweyer S., Obenauer S., Kang T. W., Burfeind P. (2006) Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells. J. Pathol. 208, 340–349 [DOI] [PubMed] [Google Scholar]
- 15. Schmits R., Cochlovius B., Treitz G., Regitz E., Ketter R., Preuss K. D., Romeike B. F., Pfreundschuh M. (2002) Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int. J. Cancer 98, 73–77 [DOI] [PubMed] [Google Scholar]
- 16. Welsh J. B., Sapinoso L. M., Su A. I., Kern S. G., Wang-Rodriguez J., Moskaluk C. A., Frierson H. F., Jr., Hampton G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974–5978 [PubMed] [Google Scholar]
- 17. Lee G. H., Yan C., Shin S. J., Hong S. C., Ahn T., Moon A., Park S. J., Lee Y. C., Yoo W. H., Kim H. T., Kim D. S., Chae S. W., Kim H. R., Chae H. J. (2010) BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function. Oncogene 29, 2130–2141 [DOI] [PubMed] [Google Scholar]
- 18. Xiang-yong L., Yang-chao C., Ke-yuan Z., Mei-hong Z., Hai-qing L., Hsiang-fu K., Xin Z. (2010) Overexpression of Bax inhibitor-1 (BI-1) induces cell transformation in NIH3T3 cells. Cell Biol. Int. 34, 1099–1104 [DOI] [PubMed] [Google Scholar]
- 19. Yun C. H., Chae H. J., Kim H. R., Ahn T. (2012) Doxorubicin- and daunorubicin-induced regulation of Ca2+ and H+ fluxes through human bax inhibitor-1 reconstituted into membranes. J. Pharm. Sci. 101, 1314–1326 [DOI] [PubMed] [Google Scholar]
- 20. de Mattia F., Gubser C., van Dommelen M. M., Visch H. J., Distelmaier F., Postigo A., Luyten T., Parys J. B., de Smedt H., Smith G. L., Willems P. H., van Kuppeveld F. J. (2009) Human Golgi antiapoptotic protein modulates intracellular calcium fluxes. Mol. Biol. Cell 20, 3638–3645 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Saraiva N., Prole D. L., Carrara G., Johnson B. F., Taylor C. W., Parsons M., Smith G. L. (2013) hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J. Cell Biol. 202, 699–713 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kim H. R., Lee G. H., Ha K. C., Ahn T., Moon J. Y., Lee B. J., Cho S. G., Kim S., Seo Y. R., Shin Y. J., Chae S. W., Reed J. C., Chae H. J. (2008) Bax inhibitor-1 is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum. J. Biol. Chem. 283, 15946–15955 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Ahn T., Yun C. H., Chae H. Z., Kim H. R., Chae H. J. (2009) Ca2+/H+ antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes. FEBS J. 276, 2285–2291 [DOI] [PubMed] [Google Scholar]
- 24. Lee G. H., Ahn T., Kim D. S., Park S. J., Lee Y. C., Yoo W. H., Jung S. J., Yang J. S., Kim S., Muhlrad A., Seo Y. R., Chae S. W., Kim H. R., Chae H. J. (2010) Bax inhibitor 1 increases cell adhesion through actin polymerization: involvement of calcium and actin binding. Mol. Cell. Biol. 30, 1800–1813 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Carrara G., Saraiva N., Gubser C., Johnson B. F., Smith G. L. (2012) Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J. Biol. Chem. 287, 15896–15905 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Bultynck G., Kiviluoto S., Henke N., Ivanova H., Schneider L., Rybalchenko V., Luyten T., Nuyts K., De Borggraeve W., Bezprozvanny I., Parys J. B., De Smedt H., Missiaen L., Methner A. (2012) The C terminus of Bax inhibitor-1 forms a Ca2+-permeable channel pore. J. Biol. Chem. 287, 2544–2557 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Saraiva N., Prole D. L., Carrara G., Maluquer de Motes C., Johnson B. F., Byrne B., Taylor C. W., Smith G. L. (2013) Human and viral Golgi anti-apoptotic proteins (GAAPs) oligomerize via different mechanisms and monomeric GAAP inhibits apoptosis and modulates calcium. J. Biol. Chem. 288, 13057–13067 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Chang Y., Bruni R., Kloss B., Assur Z., Kloppmann E., Rost B., Hendrickson W. A., Liu Q. (2014) Structural basis for a pH-sensitive calcium leak across membranes. Science 344, 1131–1135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403–410 [DOI] [PubMed] [Google Scholar]
- 30. Thompson J. D., Higgins D. G., Gibson T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673–4680 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Valdar W. S. (2002) Scoring residue conservation. Proteins 48, 227–241 [DOI] [PubMed] [Google Scholar]
- 32. Kyte J., Doolittle R. F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105–132 [DOI] [PubMed] [Google Scholar]
- 33. Parker A. K., Gergely F. V., Taylor C. W. (2004) Targeting of inositol 1,4,5-trisphosphate receptors to the endoplasmic reticulum by multiple signals within their transmembrane domains. J. Biol. Chem. 279, 23797–23805 [DOI] [PubMed] [Google Scholar]
- 34. Kota J., Gilstring C. F., Ljungdahl P. O. (2007) Membrane chaperone Shr3 assists in folding amino acid permeases preventing precocious ERAD. J. Cell Biol. 176, 617–628 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Mumberg D., Müller R., Funk M. (1995) Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156, 119–122 [DOI] [PubMed] [Google Scholar]
- 36. Drew D., Newstead S., Sonoda Y., Kim H., von Heijne G., Iwata S. (2008) GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae. Nat. Protoc. 3, 784–798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Singh S., Hedley D., Kara E., Gras A., Iwata S., Ruprecht J., Strange P. G., Byrne B. (2010) A purified C-terminally truncated human adenosine A(2A) receptor construct is functionally stable and degradation resistant. Protein Expr. Purif. 74, 80–87 [DOI] [PubMed] [Google Scholar]
- 38. Fertig N., Klau M., George M., Blick R. H., Behrends J. C. (2002) Activity of single ion channel proteins detected with a planar microstructure. Appl. Phys. Lett. 81, 4865–4867 [Google Scholar]
- 39. Brüggemann A., George M., Klau M., Beckler M., Steindl J., Behrends J. C., Fertig N. (2003) High quality ion channel analysis on a chip with the NPC technology. Assay Drug Dev. Technol. 1, 665–673 [DOI] [PubMed] [Google Scholar]
- 40. Zhang Y. (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Roy A., Kucukural A., Zhang Y. (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725–738 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Roy A., Yang J., Zhang Y. (2012) COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res. 40, W471–W477 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Meera P., Wallner M., Song M., Toro L. (1997) Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0–S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. Proc. Natl. Acad. Sci. U.S.A. 94, 14066–14071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Yu F. H., Yarov-Yarovoy V., Gutman G. A., Catterall W. A. (2005) Overview of molecular relationships in the voltage-gated ion channel superfamily. Pharmacol. Rev. 57, 387–395 [DOI] [PubMed] [Google Scholar]
- 45. González C., Baez-Nieto D., Valencia I., Oyarzún I., Rojas P., Naranjo D., Latorre R. (2012) K+ channels: function-structural overview. Compr. Physiol. 2, 2087–2149 [DOI] [PubMed] [Google Scholar]
- 46. Cohen A., Ben-Abu Y., Zilberberg N. (2009) Gating the pore of potassium leak channels. Eur. Biophys. J. 39, 61–73 [DOI] [PubMed] [Google Scholar]
- 47. Jiang Y., Lee A., Chen J., Cadene M., Chait B. T., MacKinnon R. (2002) The open pore conformation of potassium channels. Nature 417, 523–526 [DOI] [PubMed] [Google Scholar]
- 48. Denning E. J., Woolf T. B. (2010) Cooperative nature of gating transitions in K+ channels as seen from dynamic importance sampling calculations. Proteins 78, 1105–1119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Brelidze T. I., Niu X., Magleby K. L. (2003) A ring of eight conserved negatively charged amino acids doubles the conductance of BK channels and prevents inward rectification. Proc. Natl. Acad. Sci. U.S.A. 100, 9017–9022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Kew J., Davies C. (2010) Ion Channels: From Structure to Function, 2nd Ed., pp. 20–28, Oxford University Press, Oxford [Google Scholar]
- 51. Kiviluoto S., Schneider L., Luyten T., Vervliet T., Missiaen L., De Smedt H., Parys J. B., Methner A., Bultynck G. (2012) Bax inhibitor-1 is a novel IP3 receptor-interacting and -sensitizing protein. Cell Death Dis. 3, e367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Bultynck G., Kiviluoto S., Methner A. (2014) Bax inhibitor-1 is likely a pH-sensitive calcium leak channel, not a H+/Ca2+ exchanger. Sci. Signal. 7, pe22. [DOI] [PubMed] [Google Scholar]
- 53. OuYang B., Chou J. J. (2014) The minimalist architectures of viroporins and their therapeutic implications. Biochim. Biophys. Acta 1838, 1058–1067 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Pinto L. H., Holsinger L. J., Lamb R. A. (1992) Influenza virus M2 protein has ion channel activity. Cell 69, 517–528 [DOI] [PubMed] [Google Scholar]
- 55. Chizhmakov I. V., Geraghty F. M., Ogden D. C., Hayhurst A., Antoniou M., Hay A. J. (1996) Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J. Physiol. 494, 329–336 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Gonzalez M. E., Carrasco L. (2003) Viroporins. FEBS Lett. 552, 28–34 [DOI] [PubMed] [Google Scholar]
- 57. Griffin S. D., Beales L. P., Clarke D. S., Worsfold O., Evans S. D., Jaeger J., Harris M. P., Rowlands D. J. (2003) The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 535, 34–38 [DOI] [PubMed] [Google Scholar]
- 58. Pavlović D., Neville D. C., Argaud O., Blumberg B., Dwek R. A., Fischer W. B., Zitzmann N. (2003) The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc. Natl. Acad. Sci. U.S.A. 100, 6104–6108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Wang K., Xie S., Sun B. (2011) Viral proteins function as ion channels. Biochim. Biophys. Acta 1808, 510–515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Nieva J. L., Madan V., Carrasco L. (2012) Viroporins: structure and biological functions. Nat. Rev. Microbiol. 10, 563–574 alc/ [DOI] [PMC free article] [PubMed] [Google Scholar]